Regeneron-Sanofi food allergy drug succeeds mid-stage study

(Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat infection in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.